Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses

v3.20.1
Accrued Expenses
3 Months Ended
Mar. 31, 2020
Payables And Accruals [Abstract]  
Accrued Expenses

8. Accrued Expenses

Accrued expenses consisted of the following as of March 31, 2020 and December 31, 2019 (in thousands):

 

 

 

March 31, 2020

 

 

December 31, 2019

 

External research and preclinical development

 

$

4,839

 

 

$

5,395

 

Employee compensation and benefits

 

 

1,652

 

 

 

4,174

 

Professional fees

 

 

309

 

 

 

694

 

Facilities and other

 

 

43

 

 

 

383

 

 

 

$

6,843

 

 

$

10,646